Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial have?
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial has 591 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial published?
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial has 2009 year in the ScholarIQ index.
What is the open-access status of Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial?
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial has closed oa status in the ScholarIQ index.
What is the DOI of Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial?
The DOI for Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial is on the source record.
What is the PMID of Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial?
The PMID for Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial is on the source record.
What is the OpenAlex record for Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial?
The OpenAlex for Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial is on the source record.